Silence Therapeutics, Plc. earnings per share and revenue

SLNCF earnings per share for the last quarter are -0.01 USD whereas the estimation was -0.04 USD which accounts for 85.39% surprise. Company revenue for the same period amounts to 15.66 M USD despite the estimated figure of 6.35 M USD. Estimated earnings per share for the next quarter are -0.04 USD, and revenue is expected to reach 11.70 M USD. Also watch annual changes over time to get a bigger picture of SLNCF earnings per share and revenue dynamics.